¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

Æ÷½ºÅÍ À¯ÀÇ»çÇ×

9¿ù 24ÀÏ(¸ñ) ¿ÀÀü 9½Ã ÀÌÀü±îÁö Æ÷½ºÅ͸¦ ºÎÂøÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¿ÀÀü 9½ÃºÎÅÍ "ÃÖ¿ì¼ö Æ÷½ºÅÍ»ó" ½É»ç°¡ ½ÃÀ۵˴ϴÙ.

1. Å© ±â : 63.6cm(°¡·Î) X 93.6cm(¼¼·Î)
2. ¼³Ä¡¹æ¹ý : Final ÇÁ·Î±×·¥Áö¿¡ °ÔÀçµÈ ÃÖÁ¾ Æ÷½ºÅÍ ¹øÈ£¸¦ ¹Ýµå½Ã È®ÀÎÇÑ ÈÄ,
        ÇØ´ç Æ÷½ºÅÍ ÆdzÚÀÇ ÇÏ´Ü°ú »ó´ÜÀ» ¸ÂÃß¾î ºÎÂø ºÎÂøÀç·á´Â °³º°Áغñ
3. Àü½Ã±â°£ : 2009³â 9¿ù 24ÀÏ(¸ñ) ¿ÀÀü 9½Ã ~ 26ÀÏ(Åä) ¿ÀÀü 11½Ã

26ÀÏ(Åä) ¿ÀÀü 11½ÃºÎÅÍ Æ÷½ºÅÍ ÆdzÚÀÌ Ã¶¼öµÇ¿À´Ï ¿ÀÀü 10½Ã~11½Ã »çÀÌ¿¡ Æ÷½ºÅ͸¦ Å»ÂøÇϽñ⠹ٶø´Ï´Ù.

Æ÷½ºÅÍ - Àüü   /    ¸ðüžÆÀÇÇР  /    ºÎÀÎÁ¾¾çÇР  /    »ý½Ä³»ºÐºñÇР  /    ÀϹݺÎÀΰúÇÐ

[ Æ÷½ºÅÍ - ºÎÀÎÁ¾¾çÇÐ ]

Exhibition Hall B
¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
GO1 ±Ç¼ö°æ ¿ï»êÀÇ´ë Do clear cell carcinomas have poorer survival than serous carcinomas of ovary? A case-control study
GO2 ÀüÀºÁø ¿ï»êÀÇ´ë Treatment outcome of carcinosarcoma of ovary: Comparison with serous epithelial ovarian carcinoma
GO3 ÀÓ¸íö ±¹¸³¾Ï¼¾ÅÍ Àڱþϼ¾ÅÍ Clinical Maniestations in Patients with Endometrioid Epithelial Ovarian Cancer With or Without Co-existing Endometriosis: A Multicenter Retrospective Study
GO4 ÀÓ¸íö ±¹¸³¾Ï¼¾ÅÍ Àڱþϼ¾ÅÍ Region-based Diagnostic Performance of Multi-detector CT for Detecting Peritoneal Seeding in Ovarian Cancer Patients
GO5 À̽ÅÈ­ ¿ï»êÀÇ´ë Effective radiation therapy for recurrent epithelial ovarian cancer after chemotherapy as the palliative and salvage treatment
GO6 ÀÌ»êÈñ ¿¬¼¼ÀÇ´ë The impact of lymph node ratio on tumor recurrence and survival after staging laparotomy for advanced epithelial ovarian cancer
GO7 Àü°æö ¿ï»êÀÇ´ë Optimal debulking surgery followed by paclitaxel /platinum chemotherapy; Effective management in ovarian malignant mixed mullerian tumors
GO8 ÀÌÁ¤¿ø °¡Å縯ÀÇ´ë Clinical outcomes of atypical borderline ovarian tumor
GO9 Á¤¾ð¼® °Ç¾çÀÇ´ë The impact of laparoscopically-assisted staging surgery for ovarian or tubal cancers : Intermediate-term oncologic outcomes
GO10 À±¼®±Ù °üµ¿ÀÇ´ë Second-look laparoscopy in advanced epithelial ovarian cancer
GO11 °­¿ì´ë Àü³²ÀÇ´ë Value of Serum CA125 Levels in Patients with High-risk, Early Stage Epithelial Ovarian Cancer
GO12 À±Àç¿ø ¿ï»êÀÇ´ë Outcomes of fallopian tube carcinoma treated with cytoreductive surgery followed by adjuvant platinum-based chemotherapy
GO13 ¹ÚÁ¤¿­ ¿ï»êÀÇ´ë Management of occult invasive cervical cancer found after simple hysterectomy
GO14 ±è¿ì¿µ ¾ÆÁÖÀÇ´ë Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: A single institution¡¯s experience over 14 years
GO15 ±èÀçÁØ ¿ï»êÀÇ´ë Comparison of chemotherapy and concurrent chemoradiotherapy as adjuvant treatment in cervical cancer patient with intermediate and high risk factors: A matched case-control study
GO16 ÃÖÈ«ÁØ °üµ¿ÀÇ´ë Neoadjuvant Chemotherapy with Paclitaxel and Platinum in Uterine Cervical Cancer: Histologic Clinicopathologic Outcome of Squamous Cell Carcinoma Versus Adenocarcinoma
GO17 ±è¹Ì°æ ¼­¿ïÀÇ´ë Feasibility of conservative management for stage IB1 cervical cancer with invasion depth of less than 5 mm (microinvasive carcinoma)
GO18 ±èÈñ½Â ¼­¿ïÀÇ´ë Concealing Effect by Neoadjuvant Chemotherapy in FIGO stage IB1-IIA Cervical Cancer
GO19 Jintendra Pariyar ¿ï»êÀÇ´ë Diagnostic accuracy of magnetic resonance imaging in predicting myometrial invasion and cervical involvement in endometrial cancer
GO20 °ûÇö¼º °¡Å縯ÀÇ´ë Effect of systematic pelvic lymphadenectomy in early stage endometrial cancer: a randomized study in Korea
GO21 ±èÈñ½Â ¼­¿ïÀÇ´ë Impact of Lymphadenectomy on Survival in Endometrial Carcinoma: A Systematic Review and Meta-analysis
GO22 ±èÈñ½Â ¼­¿ïÀÇ´ë Value of Serum CA-125 levels for Preoperative Counseling in Endometrioid Endometrial Cancer
GO23 ÀÓÇü¼ö ¼­¿ïÀÇ´ë Clinical Analysis of 15 Cases of Low Grade Endometrial Stromal Sarcoma
GO24 ±è¿ìö °üµ¿ÀÇ´ë Conservative Treatment with Progestin And Pregnancy Outcomes in Complex Endometrial Hyperplasia with Atypia
GO25 ¹Ú»ó¹Î ¿ï»êÀÇ´ë Àç¹ß¼º Àڱà À°Á¾ÀÇ ÀÓ»ó ¾ç»ó°ú ¿¹ÈÄÀÎÀÚ¿¡ °üÇÑ ¿¬±¸
GO26 ±èº¸¿í ¿¬¼¼ÀÇ´ë The period of hCG follow up may be shortened in the women who achieve spontaneous normalization of hCG after evacuation of hydatidiform mole
GO27 ±è¼±¿µ ¿¬¼¼ÀÇ´ë Menopause induced by chemotherapy for GTD
GO28 ¼Õâ¾÷ ¼º±Õ°üÀÇ´ë ³­¼Ò ¼¶À¯Á¾¿¡ ´ëÇÑ °­ºÏ»ï¼ºº´¿øÀÇ °æÇè°ú ÀÓ»óÀû °íÂû
GO29 ÀÌÁ¤¿ø °¡Å縯ÀÇ´ë À¯¹æ¿ÜÆÄÁ¦Æ®º´ÀÇ ÀÓ»óÀû, º´¸®ÇÐÀû °íÂû
GO30 ³ëÇöÁø ¿ï»êÀÇ´ë Paget¡¯s disease of the vulva: Evaluation of recurrence relative to symptom duration, volumetric excision of lesion and surgical margin status
GO31 ÇÑÈ£¼· °üµ¿ÀÇ´ë The Adequacy of Conization in the Management of Adenocarcinoma in situ of the Uterine Cervix
GO32 ¼ÒÀºÁ¤ ¼­¿ïÀÇ´ë Intentional follow up strategy after loop electrosurgery excision procedure (LEEP) for patients with cervical intraepithelial neoplasia (CIN) 2, 3.
GO33 ÃÖÈ«ÁØ °üµ¿ÀÇ´ë Clinical and Histological Significance of Atypical Glandular Cells on Cervical Cytology
GO34 °­¿ì´ë Àü³²ÀÇ´ë Distribution of high-risk human papillomavirus genotypes among older women
GO35 À̼ºÁ¾ °¡Å縯ÀÇ´ë A real time optoelectronic device and colposcopic Reid index in assessment of cervical disease
GO36 ¼­¹ÎÁ¤ °¡Å縯ÀÇ´ë ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼­ÀÇ Mullerian Inhibiting SubstanceÀÇ Áõ½Ä ¾ïÁ¦ È¿°ú
GO37 Á¤´ëÈÆ ÀÎÁ¦ÀÇ´ë Costimulatory B7-H1 expression in cervical cancer patients
GO38 ÀÓ¸íö ±¹¸³¾Ï¼¾ÅÍ Àڱþϼ¾ÅÍ Expression of carbonic anhydrase XII in cervical cancer is associated with differentiation status and superior radiotherapy outcome
GO39 È«ÁøÈ­ °í·ÁÀÇ´ë Expression pattern of the class I homeobox genes in ovarian carcinoma
GO40 äµÎº´ ¿¬¼¼ÀÇ´ë ER-60 (PDIA3) protein is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139
GO41 Á¶ÇѺ° ¿¬¼¼ÀÇ´ë Expression and function of glucose transporter-1 (GLUT-1) in epithelial ovarian cancer
GO42 ±èº¸¿í ¿¬¼¼ÀÇ´ë Overexpression and role of reptin in ovarian cancer
GO43 Á¶¹«¼º ºÎ»êÀÇ´ë The significance of secreted protein acidic and rich in cysteine(SPARC) in epithelial ovarian cancer
GO44 ±è±âÇü ºÎ»êÀÇ´ë KSP inhibitor ARRY-520 as a substitute for Paclitaxel in MyD88-positive Epithelial ovarian cancer cells
GO45 ÀÓ¹ýÀÎ ¿ø±¤ÀÇ´ë Ç×¾ÏÁ¦ÀÎ CisplatinÀ¸·Î ó¸®µÈ ¹è¾ç¼¶À¯¸ð¼¼Æ÷¿¡ ´ëÇÑ Gallic AcidÀÇ Ç×»êÈ­ È¿°ú¿¡ °üÇÑ ¿¬±¸
GO46 ÀÌÁ¤¿ø ¼º±Õ°üÀÇ´ë The Role of MicroRNA-200 family as Therapeutic Targets in Human Endometrial Cancer
GO47 ÃÖöÈÆ ¼º±Õ°üÀÇ´ë Expression of eIF4E and mTOR in endometrial cancer
GO48 °ø°Ç¿µ ¿ï»êÀÇ´ë The Comparison of the Proportion of Peripheral Blood Myeloid-derived Suppressor Cells between gynecologic cancer patients and healthy women
GO49 ¹®¼ºÀº ÁÁÀº¹®È­º´¿ø ÀڱñÙÁ¾°ú Á¤»óÁ¶Á÷¿¡¼­ hedgehog ½ÅÈ£Àü´Þü°èÀÇ sonic hedgehog À¯ÀüÀÚ ¹ßÇö ºñ±³
GO50 ¹éÁöÈì ¿¬¼¼ÀÇ´ë Two-port staging laparoscopy for endometrial cancer: The first two cases report
GO51 Á¤¿ë¿í ¿¬¼¼ÀÇ´ë The feasibility of scarless single port transumbilical total laparoscopic hysterectomy: Initial clinical experiences
GO52 ÃÖ¿µ¹Ì ¿¬¼¼ÀÇ´ë Single-port transumbilical laparoscopic approach for adenxal surgery in gynecology
GO53 ±è¼ö³ç °Ç±¹ÀÇ´ë Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES) for Ovarian Cyst
GO54 À̽ÂÈ£ °¡ÃµÀÇ´ë Àڱ󻸷¾Ï ȯÀÚÀÇ °ñ¹Ðµµ¿¡ °üÇÑ ¿¬±¸
GO55 ȲÁ¾ÇÏ °í·ÁÀÇ´ë Bone mineral density in patients with uterine cervical cancer after concurrent chemoradiation
GO56 ±âÀº¿µ °¡Å縯ÀÇ´ë Basal cell carcinoma of the vulva
GO57 Á¶´öÇö ºÎ»êÀÇ´ë Bowen º´ ȯÀÚ¿¡¼­ ¹ß»ýÇÑ HPV infection ÀÌ µ¿¹ÝµÈ ¿ÜÀ½ºÎ»óÇdz»¾Ï ¹× ÀڱðæºÎ»óÇdz»º´º¯
GO58 äÈñ¼÷ ÀüºÏÀÇ´ë Paget¡¯s disease of the vulva : report to two cases
GO59 °­È£Á¤ Á¦ÁÖÀÇ´ë syringoma of the vulva
GO60 Á¤À±Áö °¡Å縯ÀÇ´ë Aggressive angiomyxoma of the vulva: a case report
GO61 À̼ºÇÏ °¡Å縯ÀÇ´ë Primary malignant melanoma of the vagina
GO62 °øÅÂ¿í ¾ÆÁÖÀÇ´ë Sarcomatoid squamous cell carcinoma of the uterine cervix successfully treated by laparoscopic radical hysterectomy
GO63 Á¶Çý¿¬ ÇѸ²ÀÇ´ë A case of clear cell adenocarcinoma in the uterine cervix of 52-year-old virgin
GO64 À̼ºÀÇ ºÎ»êÀÇ´ë ÀúÇ÷´çÀ» µ¿¹ÝÇÑ Èĺ¹¸· ³» À¯»óÇÇ Ç÷°ü³»ÇÇÁ¾¾ç 1·Ê
GO65 ÃÖÀÏÁ¤ µ¿¾ÆÀÇ´ë A case of sertoli-leydig cell tumor of ovary with virilization
GO66 Á¤±Ù¿À °æºÏÀÇ´ë Vaginal evisceration after total laparoscopic radical hysterectomy in cervical cancer
GO67 ÁöÀº¿µ °¡Å縯ÀÇ´ë Can laparoscopy really complete full surgical staging? A case of early recurrence and malignant transformation of serous borderline ovary tumor
GO68 °û¼¼Çö °¡Å縯ÀÇ´ë Ovarian cancer at young age: clinicopathologic characteristics and prognosis of epithelial ovarian cancer before age 20
GO69 ¼Û¹ÎÁ¾ °¡Å縯ÀÇ´ë ¾çÃø ³­¼Ò¿¡¼­ µ¿½Ã¿¡ ¹ß°ßµÈ ¼­·Î ´Ù¸¥ Á¶Á÷ÇÐÀû ¼Ò°ß(ÁÂÃø³­¼Ò; Serous papillary adenocarcinoma, ¿ìÃø; Mallignant mixed Mullerian tumor)ÀÇ ¾çÃø ³­¼Ò¾Ï 1¿¹
GO70 ¹Ú±Ù½Ä ÁÁÀº¹®È­º´¿ø A unusual case of ovarian fibroma with extensive calcification
GO71 ±ÇÇÏ¾á ¿¬¼¼ÀÇ´ë Krukenberg tumor arising from breast cancer : a case of the youngest patient in Korea
GO72 Á¤Áö¾È ¿¬¼¼ÀÇ´ë A case report of gynandroblastoma from ovary : The first case in Korea
GO73 Á¤Áö¿µ °í½ÅÀÇ´ë Primary Granulocytic Sarcoma of Ovary-A Rare Case Report
GO74 °í¿µº¹ Ãæ³²ÀÇ´ë ¹Ì¼º¼÷±âÇüÁ¾ ¼ö¼úÈÄ °£¿¡ ¹ß»ýÇÑ ¼º¼÷±âÇüÁ¾ 1¿¹
GO75 ±èÁöÇö ÇѸ²ÀÇ´ë ³­¼ÒÀÇ ¹Ì¼º¼÷ ±âÇüÁ¾¿¡ °üÇÑ 2¿¹
GO76 ÃÖÅ¿µ ÁÁÀº¹®È­º´¿ø º¹ÀâÇÑ ¿°»öü ÀÌ»óÀ» ³ªÅ¸³»´Â ÀڱñÙÁ¾ 2·ÊÀÇ ¼¼Æ÷À¯ÀüÇÐÀû °íÂû
GO77 ¹èÁöÇý °æºÏÀÇ´ë Adenomyomatous polyp of uterus in Peutz-Jeghers syndrome
GO78 ¼­¹ÎÁ¤ °¡Å縯ÀÇ´ë ÀÚ±ÃüºÎ¿¡ ¹ß»ýÇÑ ¾Ç¼º ¸²ÇÁÁ¾ 1¿¹
GO79 Á¤À±¾Æ ÇѸ²ÀÇ´ë ÀڱðæºÎ ¹Ì¼¼Ä§À±»ù¾ÏÁ¾ ȯÀÚ¿¡¼­ °ñ¹Ý ¸²ÇÁÀý ÀüÀÌ 1¿¹
GO80 ÀÌ°æÈñ ÇѸ²ÀÇ´ë Àç¹ß¼º Àڱà °æºÎ¾ÏÀÇ ¼­Ç츲ÆÄÀý ´Üµ¶ÀüÀÌ 1¿¹
GO81 ÃÖÀ±Áø °¡Å縯ÀÇ´ë The Trickery of increased FDG Uptake on PET CT in Foreign-body Reaction; a Case Report